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319 Effects of maternal depression on electronically monitored
enzyme adherence and changes in weight for children with CF
A.L. Quittner1, D.H. Barker1, D. Geller2, S. Butt3, M. Gondor3. 1University of
Miami, Coral Gables, FL, USA; 2Nemours Children’s Clinic, Orlando, FL, USA;
3All Children’s Hospital, Tampa, FL, USA
Objectives: Few studies have documented relationships between caregiver depres-
sion, treatment adherence and medical outcomes in CF. Further, no studies have
employed electronic monitors to measure enzyme adherence. This study examined
the effects of caregiver depression on electronically monitored enzyme adherence
over a three-month period in relation to changes in weight percentiles for children
with CF.
Methods: As part of a larger intervention study at 3 CF Centers, 88 children with
CF ages 1 to 11 and their parents participated. Parents completed a standard measure
of depression (CESD) at enrollment and were provided with pill caps recording the
date and time of each bottle opening. Standard health outcomes were also assessed
at enrollment and 3 months later.
Results: Caregivers reported elevated levels of depression, with 30% scoring in
the clinical range. Rates of adherence to enzymes was poor (43% at home and
48% at school). Caregiver depression was negatively associated with adherence,
with depressed caregivers demonstrating lower rates of adherence (11 percentage
points). Enzyme adherence was associated with changes in weight, with a 100%
adherence translating into 5 percentile points of weight gain.
Conclusions: Rates of adherence were surprisingly low and were associated with
more caregiver depression and a loss of weight over three months. Caregiver de-
pression appears to be under-diagnosed and these results suggest that more attention
should be focused on parental adjustment. Improvements in weight percentile with
better enzyme adherence highlight the need for interventions that promote adherence
in children with CF.
Funding was provided by NIH grant #69736.
320 Variance between perception score and objective score in adult
CF patients – What are the reasons for the difference?
J. Dyer, C. Hayward, H. Douglass, N.A. Jarad. Adult CF Centre, Bristol Royal
Inﬁrmary, Bristol, BS2 8HW, United Kingdom
Background: The aim of this research is to examine factors affecting the difference
between patients’ perception of their health score (PHS) and objective performance
score (OPS) in adult CF patients.
Patients and Methods: Perception of health score (PHS) was estimated by patients.
They scored their own general health status and on a scale of 0−10. Objective
performance score (OPS) was estimated on scoring system of 0−20. This was
derived by summation of four scores each from 1−5 for each of (1) breathlessness
score, (2) chest physical examination score, (3) chest radiograph score and 4. BMI
score. To match the two scores, OPS was divided by 2. Difference in scores was
calculated by subtraction of OPS from PHS (i.e. difference in score = PHS-OPS).
The difference in score was then compared between female and male CF patients
and was correlated with age, FEV1, annual number of intravenous (IV) courses of
antibiotics and treatment burden as assessed by number of regular drugs.
Results: We investigated 52 adult CF patients (20 female), mean age 26.0, range
17−42 years PHS was scored less than OPS in 29 (56%), equal to in 8 (16%) and
more than OPS in 15 (28%). There was no difference between male and female
with regards to the difference between the two scores.
The difference between scores did not correlate with FEV1, number of annual severe
exacerbations or treatment burden as identiﬁed by the amount of drugs taken by
patients.
Conclusion: In this study, most adult CF patients’ estimated their perception to
their own health to be less than an objective performance score. The difference
between the two scores did not differ according to gender and did not correlate
with recognised CF outcome measures.
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Introduction: Adherence is an issue in all patients with CF. The essence of care
requires a lifelong commitment, juggling aggressive treatment of infection with an
acceptable quality of life. Managing this challenges patient, family & team. CF
studies cite adherence rates from 20−90%, highlighting the problem, but do not
provide insight regarding team opinion or adherence management.
Objectives: The aim was to explore CF team opinions of adherence, relating
to patient age, treatment, potential for a screening tool & what could improve
adherence.
Methodology: A short questionnaire designed speciﬁcally for this study was piloted
at a London CF meeting, then emailed to Nurse Specialists.
Results: Questionnaires were sent to 49 UK CF teams. 129 professionals responded
(47% CNS, 16% Doctors, 19% Physiotherapists, 12% Dietitians, 4% Psychologists
& 2% Pharmacists). All felt adherence is a problem.65% stated adolescents present
with the majority of adherence issues. Treatments cited as most problematical were
physio 29%, medications & physio 41%, variable 12%, nebulisers 9%, supplements
& enzymes 6%, none stated 3%. 43% thought a screening tool would be useful
(10% did not, 47% thought maybe). The following screening tools were selected;
questionnaires (30%), clinic interviews (40%), telephone/mobile survey (14%), any
tool (7%), 9% no response. Respondents stated a decreased treatment burden (24%),
patient education/empowerment (20%), treatment negotiation (18%), family/peer
support (14%), patient motivation (6%) & an adherence monitoring/reward scheme
(4%) could improve adherence.
Conclusion: Professionals report adherence is a signiﬁcant problem mainly in
adolescents & with a variety of treatments, especially physiotherapy. A screening
tool may be beneﬁcial to detect poor adherence, but what will improve it is yet to
be proven.
322 Danish lung transplanted CF patients connection to the labour
market prior to and after the transplantation
L.D. Lund, H.E. Jacobsen. Danish CF Centre-Copenhagen, Rigshospitalet,
Copenhagen, Denmark
Introduction: Because of improved treatment most Danish CF patients get a
connection to the labour market. 56 Danish CF patients have been are lung
transplanted since 1990 (29 females). Living 38 patients (22 females). Most of these
patients receive early retirement pension prior to transplantation and we suppose
most of the patients still receive pension after the transplantation. We believe there
could be a missing guidance to return to labour market.
Aim: To investigate the connection to the labour market before and after the lung
transplantation. To see if there is a connection between how long they received
pension prior to transplantation compared to how long they remain on pension
after the transplantation. We also want to see if the patients received any guidance
to return to labour market.
Methods: Telephone interview with 30 Danish lung transplant patients (18 females).
Results: 27 patients participated in this study. Prior transplantation: 21 patients
received early retirement pension (5 patients received pension just before trans-
plantation and 16 patients received pension on the average 11.5 years before trans-
plantation). 4 patients were studying and 2 worked full time. After transplantation:
19 patients received early retirement pension, 4 studying and 4 back to work (3 full
time and 1 part time).
Conclusion: Most patients receiving early retirement pension many years before
the transplantation continues to receive pension after the transplantation. Younger
patients studying before transplantation, continue their study after transplantation.
None of the patients have received guidance about returning to labour market after
the transplantation.
